The National Agency for Food and Drug Administration Control (NAFDAC) has raised alarm over fake coronavirus vaccines in Nigeria, stressing that no vaccines have been approved by the agency
Penpushing reports that Director General of the agency, Prof Mojisola Adeyeye made this known in a statement, stressing that, if such vaccines are not approved by the relevant authorities, it makes it fake
‘The National Agency for Food and Drug Administration and Control (NAFDAC) has not received any application from Covid Vaccine manufacturers yet and therefore no vaccines have been approved by NAFDAC’, she declared.
‘Covid-19 vaccines are new, and the side effects or adverse events must be well monitored, therefore, if NAFDAC does not approve, the public should not use’, Adeyeye emphasised.
Penpushing further reports that, the agency cautioned Nigerians and other residents to beware of the vaccines, explaining that it can cause coronavirus-like illness and other serious disease that could kill
‘There are reports of fake vaccines in Nigeria. NAFDAC is pleading with the public to beware. No Covid Vaccines have been approved by NAFDAC. Fake vaccines can cause Covid-like illnesses or other serious diseases that could kill’.
Penpushing also reports that, the agency warned companies and corporations not to order for the vaccines, stressing that if the manufacturers are genuine companies to ought to know that they have to submit their application to the agency.
‘Vaccines should not be ordered by any company or corporation. The companies that manufacture the vaccines if they are genuine companies know they have to submit their application to NAFDAC’.
Penpushing reports that, Adeyeye declared that, no government establishment or agencies should order for the vaccines without confirming from agency if the vaccine has been approved.
‘However, NAFDAC is discussing with manufactures of candidate COVID-19 vaccines concerning potential Emergency Use Authorization (EUA), registration or licensing of their product as the case may be’.
‘The Agency assures applicants that if Phase 3 clinical data are very convincing and robust with regards to safety and efficacy, and the vaccine has been submitted for WHO for Emergency Use Listing, NAFDAC will welcome the application for Emergency Use Authorisation in Nigeria’.
FOOTNOTE: You want to share story with us? You want to advertise with us? You need publicity for product, or service, or event? Contact us on WhatsApp +2348073463653 or email penpushing@yahoo.com
